Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| American Cancer Society, Inc. | OTHER |
| Pfizer | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Comorbidities in breast cancer survival account for 49% of overall survival difference between black and white women. Many obesity-related comorbidities disproportionately affect black women, therefore pointing to a need to address obesity related comorbidities in survival disparities in early breast cancer patients. This study tinvestigates how messages and messaging about healthy weight can be tailored for racially diverse breast cancer survivors with obesity in order to ensure that clinic-based communications between patients and their oncology provider are patient-centered and culturally sensitive.
The overall goal of this research is to collect essential input for the future development of a quality improvement intervention to foster "Patient-Center Communication about Healthy Weigh in clinical practice
Primary Objective:
Understand patient-centered perspectives on health weight communication with oncology clinicians by conducting focus groups
Secondary Objective
Understand oncology clinician perspectives on patient center communications for healthy weight interactions through semi-structured interviews.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Early Breast Cancer Patients | Early breast cancer patients (Stage I-III) who have completed primary treatment with a current Body mass index (BMI) over 30. |
| |
| Medical Oncology Clinicians | Oncology providers associated with community-based practices |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Focus Group | Other | Breast cancer patients and oncology clinicians will participate in separate focus groups discussing patient-centered communication about healthy weight. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Feedback from patients regarding healthy weight communication through focus groups | Summary of conversation based on 5A's Behavioral Change Model | 3 year |
| Measure | Description | Time Frame |
|---|---|---|
| Feedback from oncology providers regarding healthy weight communication through semi-structured interview | Provider suggestions on how to implement 5A's Behavioral change model into patient care | 3 year |
Not provided
Inclusion Criteria for Breast Cancer Cohort:
Exclusion Criteria:
INclusion Criteria for Oncology provider cohort:
Not provided
Not provided
Breast Cancer patients and Breast oncology providers will be eligible for this study
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kirsten Nyrop, PhD | University of North Carolina, Chapel Hill | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | United States |
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D017144 | Focus Groups |
| ID | Term |
|---|---|
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D017531 | Health Care Evaluation Mechanisms |
Not provided
Not provided
Not provided
Not provided
Not provided
| D017437 |
| Skin and Connective Tissue Diseases |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |